ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 43 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $153,000 | +856.2% | 359,982 | +1376.1% | 0.00% | – |
Q4 2016 | $16,000 | -81.2% | 24,387 | -10.1% | 0.00% | – |
Q3 2016 | $85,000 | +39.3% | 27,139 | +38.6% | 0.00% | – |
Q2 2016 | $61,000 | +1.7% | 19,582 | +18.9% | 0.00% | – |
Q1 2016 | $60,000 | -97.5% | 16,468 | -96.9% | 0.00% | – |
Q4 2015 | $2,432,000 | -9.6% | 524,175 | +18.7% | 0.00% | – |
Q3 2015 | $2,690,000 | +287.6% | 441,632 | +448.2% | 0.00% | – |
Q2 2015 | $694,000 | +601.0% | 80,567 | +263.7% | 0.00% | – |
Q1 2015 | $99,000 | +65.0% | 22,154 | -41.7% | 0.00% | – |
Q4 2014 | $60,000 | – | 37,971 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,431,196 | $2,748,000 | 1.18% |
Abingworth LLP | 437,994 | $832,000 | 0.50% |
Broadfin Capital, LLC | 1,301,622 | $2,499,000 | 0.26% |
Rhenman & Partners Asset Management AB | 400,000 | $768,000 | 0.22% |
BVF INC/IL | 559,624 | $1,074,000 | 0.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $3,248,000 | 0.12% |
Perceptive Advisors | 478,456 | $919,000 | 0.10% |
Gruss Capital Management LP | 1,720,000 | $3,302,000 | 0.08% |
SECTORAL ASSET MANAGEMENT INC | 247,961 | $476,000 | 0.02% |
Spark Investment Management LLC | 36,400 | $69,000 | 0.01% |